Sun Pharma, Philogen seek EMA marketing nod for skin cancer treatment Nidlegy Ruchika Sharma4 Jun 2024 4:45 PM ISTMumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced the submission of a Marketing Authorization Application (MAA)...
GSK disagrees with ruling by Delaware State Court on ranitidine litigation, to seek appeal Ruchika Sharma3 Jun 2024 2:41 PM ISTLondon: GSK plc has announced that it disagrees with the ruling by the Delaware State Court and will immediately seek an appeal. The decision by...
HPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows Dr. Kamal Kant Kohli2 Jun 2024 8:45 PM ISTThe human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being...
USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma Ruchika Sharma1 Jun 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Results of Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024 Ruchika Sharma1 Jun 2024 11:30 AM ISTMumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced that the primary results of the Nidlegy Phase III PIVOTAL...
Active surveillance in low risk prostate cancer patients effective management option to immediate surgery or radiation: JAMA Dr Riya Dave1 Jun 2024 3:30 AM ISTResearchers from Fred Hutch Cancer Center have found that active surveillance for prostate cancer patients with a low risk of progression is an...
Study Finds Increased Risk of Malignant Lymphoma Closely Linked to Tattoos Jacinthlyn Sylvia30 May 2024 7:00 PM ISTIn recent times, tattoos have gained popularity by becoming a common form of self-expression. However, new research suggests this trend might come...
Bristol Myers Squibb gets European Commission nod for Opdivo in combo with cisplatin, gemcitabine for urothelial carcinoma Ruchika Sharma30 May 2024 12:49 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with...
44-year-old man undergoes 7-hour triple surgery for Heart Disease, Gallstones, Colon Cancer at Fortis Hospital Kajal Rajput30 May 2024 9:30 AM ISTBengaluru: In a first reported case across the globe, Fortis Hospital Cunningham Road successfully conducted three simultaneous complex procedures -...
Journal Club: Systematic review and meta-analysis of studies comparing baseline D-dimer level in stroke patients with or without cancer: Strength of current evidence Dr. Nandita Mohan30 May 2024 8:15 AM ISTAn engaging review reveals that D-dimer, which is a simple and relatively non-expensive biomarker is increased to significant levels in stroke...
Nivolumab with chemotherapy improve outcomes in resectable non-small-cell lung cancer: NEJM Jacinthlyn Sylvia29 May 2024 10:00 PM ISTA new phase 3 clinical trial revealed that standard treatment with neoadjuvant nivolumab in combination with chemotherapy significantly improved the...
Roche Inavolisib gets USFDA priority review for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation Ruchika Sharma29 May 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application and granted Priority...
